Gibbs Cancer Center & Research Institute is a cancer treatment and research facility in Upstate South Carolina. Gibbs Cancer Center is associated with the NCI Community Cancer Centers Program and the Medical University of South Carolina.

During the past decade, Gibbs Regional Cancer Center at Spartanburg Regional Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 81 clinical trials were completed, i.e. on average, 405% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 19 clinical trials were completed. i.e. 633.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 54 trials, followed by "SWOG Cancer Research Network" with 53 trials sponsored, "Radiation Therapy Oncology Group" with 17 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 144 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center" are "Breast Cancer" (35 trials), "Lung Cancer" (21 trials), "Lymphoma" (14 trials), "Prostate Cancer" (13 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center" are "Drug" (140 trials), "Biological" (42 trials), "Radiation" (40 trials), "Other" (39 trials) and "Procedure" (29 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (23 trials), "radiation therapy" (21 trials), "cisplatin" (16 trials), "docetaxel" (14 trials) and "gemcitabine hydrochloride" (14 trials). Other intervention names were less common.

The vast majority of trials in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center" are 133 trials for "All" genders, 30 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Gibbs Regional Cancer Center at Spartanburg Regional Medical Center". undefined are not yet recruiting, 5 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 136 completed trials in Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, 8 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".